Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Sun Pharmaceutical Industries Limited patents


Recent patent applications related to Sun Pharmaceutical Industries Limited. Sun Pharmaceutical Industries Limited is listed as an Agent/Assignee. Note: Sun Pharmaceutical Industries Limited may have other listings under different names/spellings. We're not affiliated with Sun Pharmaceutical Industries Limited, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Sun Pharmaceutical Industries Limited-related inventors


Ertugliflozin co-crystals and process for their preparation

The present invention relates to processes for the preparation of an ertugliflozin-l-pyroglutamic acid (1:1) and co-crystal ertugliflozin-l-proline (1:1) co-crystal. The present invention further relates to an ertugliflozin-l-proline (1:2) co-crystal, processes for its preparation, and its use for the treatment of type 2 diabetes mellitus.. ... Sun Pharmaceutical Industries Limited

Parenteral dosage form of norepinephrine

The present invention relates to a ready-to-administer parenteral dosage form of norepinephrine which comprises an aqueous solution of norepinephrine, having an anti-oxidant which is not a sulfite anti-oxidant, wherein the dosage form is stable at room temperature for prolonged period of time.. . ... Sun Pharmaceutical Industries Limited

Drug delivery device for pharmaceutical compositions

The present invention relates to a dual-chamber pack with a first chamber comprising a container; and a second chamber comprising a reservoir, a biphasic connector, a plunger, and a plug with a breakable polymeric membrane. The container of the first chamber is prefilled with a pharmaceutically acceptable vehicle and the reservoir of the second chamber is prefilled with a solid composition of an active ingredient, wherein the solid composition of the active ingredient is mixed with the pharmaceutically acceptable vehicle to form a liquid pharmaceutical composition upon activation of the dual-chamber pack.. ... Sun Pharmaceutical Industries Limited

Once daily oral pharmaceutical composition of isotretinoin

The present invention relates to a modified-release, once-daily, oral pharmaceutical composition comprising isotretinoin and a process for its preparation. In some embodiments, the disclosure is directed to a modified-release, oral pharmaceutical composition comprising isotretinoin or a pharmaceutically acceptable salt, ester or a derivative thereof; and a release modifying agent, wherein the composition is suitable for once daily administration. ... Sun Pharmaceutical Industries Limited

Extended release liquid compositions of metformin

The present invention relates to extended release liquid compositions of metformin. The extended release liquid compositions are in the form of suspensions or reconstituted powder for suspensions. ... Sun Pharmaceutical Industries Limited

Topical spray system of halobetasol

The present invention relates to a halobetasol topical spray system comprising: (i) a composition comprising halobetasol; (ii) a dispensing system comprising: (a) a pressurized container comprising the composition and (b) a metered valve assembly comprising a metered valve having a stem connected to an actuator, wherein the actuator is provided with an insert having an orifice diameter in a range of about 0.2 mm to about 1.5 mm, wherein the actuator is depressed for activation to expel the composition from the pressurized container forming a focused coverage area. Further, said compositions are delivered from a dispensing system in metered doses.. ... Sun Pharmaceutical Industries Limited

Touch-free topical spray of halobetasol

The present invention relates to a touch-free topical spray of halobetasol comprising a composition which is delivered through a dispensing system, wherein the composition comprises from about 0.01% w/w to about 0.5% w/w of halobetasol based on the total weight of the composition for the treatment of skin disorders, wherein the dispensing system comprises a metered valve assembly comprising a metered valve having a stem connected to an actuator, wherein the actuator is provided with an insert having an orifice diameter in a range of about 0.2 mm to about 1.5 mm, and wherein no rubbing-in is required when said composition is applied to affected skin. Said topical spray compositions offer ease of application leading to enhanced patient compliance. ... Sun Pharmaceutical Industries Limited

A process for the preparation of tofacitinib citrate

The present invention provides a process for the preparation of tofacitinib citrate of formula i. Specifically, the present invention provides an enzymatic route for the preparation of tofacitinib of formula ii, which is converted to tofacitinib citrate of formula i.. ... Sun Pharmaceutical Industries Limited

Gastroretentive extended release suspension compositions

The present invention relates to a gastroretentive extended release suspension composition, wherein the composition is characterized by having no substantial change in the in-vitro dissolution release profile upon storage for at least seven days. The invention also relates to processes for the preparation of said gastroretentive extended release suspension compositions.. ... Sun Pharmaceutical Industries Limited

Processes for the preparation of ertugliflozin

The present invention relates to processes for the preparation of ertugliflozni. The present invention also provides compounds of formula (iii), formula (iv), and formula (vii), processes for their preparation, and their use for the preparation of ertugliflozin. ... Sun Pharmaceutical Industries Limited

Topical aqueous spray compositions of halobetasol

The present invention relates to topical aqueous spray compositions of halobetasol. The topical aqueous spray compositions may be in the form of solutions or emulsions. ... Sun Pharmaceutical Industries Limited

Capsule dosage form of metoprolol succinate

This disclosure provides an extended-release capsule dosage form of metoprolol succinate in the form of coated discrete units, wherein said capsule dosage form is bioequivalent to the marketed toprol-xl® tablet. The extended-release capsule dosage form comprising coated discrete units can be sprinkled onto food to ease administration to patients who have difficulty swallowing tablets or capsules.. ... Sun Pharmaceutical Industries Limited

Raloxifene sprinkle composition

The present invention relates to a capsule composition of raloxifene comprising multiparticulates comprising a) a core comprising raloxifene, and b) a taste-masking coating present in amount of from about 0.5% to about 50% w/w based on the core weight.. . ... Sun Pharmaceutical Industries Limited

Process for the preparation of baricitinib and an intermediate thereof

The present invention provides a process for the preparation of baricitinib and an intermediate thereof. The present invention provides a convenient, economical, and industrially advantageous two-step process for the preparation of [4-(ih-pyrazol-4-yl)-7hpyrrolo[2,3-d] pyrimidin-7-yl]methyl pivalate of formula (ii). ... Sun Pharmaceutical Industries Limited

11/16/17 / #20170326092

Oral pharmaceutical composition of isotretinoin

The present invention provides an oral pharmaceutical composition of isotretinoin with a reduced dose. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.. ... Sun Pharmaceutical Industries Limited

11/16/17 / #20170326091

Low dose oral pharmaceutical composition of isotretinoin

The present invention provides a low dose oral pharmaceutical composition of isotretinoin having reduced food effect, in particular no food effect. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.. ... Sun Pharmaceutical Industries Limited

11/09/17 / #20170320879

A process for the preparation of ibrutinib

The present invention provides processes for the preparation of ibrutinib, intermediate compounds of formula vi and formula viii, and salts thereof. The processes of the present invention are commercially viable, cost-effective, environmentally friendly, and make use of inexpensive, non-hazardous, safe chemicals that are easy to handle.. ... Sun Pharmaceutical Industries Limited

10/26/17 / #20170304234

Extended release liquid compositions of metformin

The present invention relates to extended release liquid compositions of metformin. The extended release liquid compositions are in the form of suspensions or reconstituted powder for suspensions. ... Sun Pharmaceutical Industries Limited

10/05/17 / #20170283455

Stable topical phamaceutical compositions of halobetasol propionate

The present invention provides a stable topical pharmaceutical composition of halobetasol propionate. The present invention discloses an impurity of compound of formula ii and its process of preparation. ... Sun Pharmaceutical Industries Limited

09/14/17 / #20170258748

Oral pharmaceutical composition of isotretinoin

The present invention provides an oral pharmaceutical composition of isotretinoin with reduced food effect. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.. ... Sun Pharmaceutical Industries Limited

09/07/17 / #20170253599

Stable amorphous ticagrelor and a process for its preparation

The present invention relates to a stable amorphous ticagrelor and a process for its preparation.. . ... Sun Pharmaceutical Industries Limited

09/07/17 / #20170252517

Leuprolide injection

The present invention provides a sterile solution comprising leuprolide acetate in a pharmaceutically acceptable vehicle, wherein solution is present as a reservoir in a multiple dose pen injection device, the device being adapted to subcutaneously inject a portion of the said reservoir in a single daily dose and further being adapted to provide multiple portions of solution said while the reservoir remains sterile.. . ... Sun Pharmaceutical Industries Limited

08/24/17 / #20170240543

Crystalline forms of palbociclib

The present invention provides crystalline form i, form ii, form iii, form iv, form v, form v-a, form vi, form vii, and form viii of palbociclib, processes for their preparation, pharmaceutical compositions comprising these crystalline forms, and their use for the treatment of cyclin-dependent kinase associated diseases.. . ... Sun Pharmaceutical Industries Limited

08/24/17 / #20170240533

Crystalline form of afatinib dimaleate

The present invention provides a crystalline form i of afatinib dimaleate, its process for preparation and pharmaceutical composition thereof, and its use in the treatment of metastatic non-small cell lung cancer.. . ... Sun Pharmaceutical Industries Limited

08/17/17 / #20170233372

Novel salts of nilotinib and polymorphs thereof

The present invention provides novel salts of nilotinib and polymorphs thereof. The acid addition salts of nilotinib with benzenesulfonic acid, butanedisulfonic acid, 1-5-naphthalenedisulfonic acid, naphthalene-1-sulfonic acid and 1-hydroxynaph-thoic acid; hydrates and anhydrates thereof.. ... Sun Pharmaceutical Industries Limited

08/03/17 / #20170217962

A process for the preparation of palbociclib

The present invention relates to a process for the preparation of palbociclib utilizing a silyl-protected crotonic acid derivative to produce a silyl-protected 2-chloro-4-(cyclopentylamino)-5-(1-methyl-2-carboxy-ethen-1-yl)pyrmidine followed by intramolecular cyclization of the pyrmidine intermediate to produce 2-chloro-8-cyclopentyl-5-methyl-8h-pyrido[2,3-d]pyrimidin-7-one which is then converted to palbociclib.. . ... Sun Pharmaceutical Industries Limited

08/03/17 / #20170216243

Parenteral dosage form of amiodarone

The present invention relates to a stable, sterile, ready to administer parenteral dosage form of amiodarone or its pharmaceutically acceptable salt. Particularly, the present invention provides a stable, sterile, ready to administer parenteral dosage form of amiodarone comprising an aqueous solution comprising amiodarone or its pharmaceutically acceptable salt, an acid, and a polyol, wherein the ph of the solution is in the range of about 2.0 to 4.0, wherein the solution is filled in a plastic container and wherein the solution is free of a solubilizer.. ... Sun Pharmaceutical Industries Limited

08/03/17 / #20170216142

Dual-chamber pack

The present invention relates to a dual-chamber pack for a multi-dose oral liquid pharmaceutical composition wherein the compositions of the first and second chambers are mixed at the time of first administration.. . ... Sun Pharmaceutical Industries Limited

07/20/17 / #20170204097

Crystalline form of baricitinib

The present invention provides a crystalline form of baricitinib characterized by an xrpd pattern substantially as depicted in fig. 1, a process for its preparation, a pharmaceutical composition comprising it, and its use for the treatment of jak-associated diseases.. ... Sun Pharmaceutical Industries Limited

07/06/17 / #20170189351

Capsule dosage form of metoprolol succinate

This disclosure provides an extended-release capsule dosage form of metoprolol succinate in the form of coated discrete units, wherein said capsule dosage form is bioequivalent to the marketed toprol-xl® tablet. The extended-release capsule dosage form comprising coated discrete units can be sprinkled onto food to ease administration to patients who have difficulty swallowing tablets or capsules.. ... Sun Pharmaceutical Industries Limited

06/22/17 / #20170174635

Process for the preparation of enzalutamide

The present invention provides a process for the preparation of enzalutamide.. . ... Sun Pharmaceutical Industries Limited

06/15/17 / #20170165218

Low dose oral pharmaceutical composition of isotretinoin

The present invention provides a low dose oral pharmaceutical composition of isotretinoin having reduced food effect, in particular no food effect. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.. ... Sun Pharmaceutical Industries Limited

06/15/17 / #20170165217

Liquid dosage forms of isotretinoin

The present invention relates to a pharmaceutical solution comprising isotretinoin or salts thereof. The present invention further relates to the processes for preparing such compositions.. ... Sun Pharmaceutical Industries Limited

06/08/17 / #20170158659

Co-crystal of dapagliflozin with citric acid

The present invention relates to a dapagliflozin-citric acid co-crystal, processes for its preparation, and its use for the treatment of type 2 diabetes mellitus. A dapagliflozin citric acid co-crystal. ... Sun Pharmaceutical Industries Limited

06/01/17 / #20170151244

Oral pharmaceutical composition of tofacitinib

The present invention relates to a dry process for the preparation of pharmaceutical compositions of tofacitinib comprising tofacitinib and one or more pharmaceutically acceptable excipients. Dry processes, such as direct compression or dry granulation, involve fewer and simpler process steps, thus preventing the loss of the active ingredient during processing.. ... Sun Pharmaceutical Industries Limited

05/11/17 / #20170129895

Amorphous form of baricitinib

The present invention provides an amorphous form of baricitinib, processes for its preparation, a pharmaceutical composition comprising it, and its use for the treatment of jak-associated diseases.. . ... Sun Pharmaceutical Industries Limited

05/04/17 / #20170119627

Dual-chamber pack for extended release suspension compositions

The present invention relates to a dual-chamber pack comprising a first chamber prefilled with a suspension base and a second chamber prefilled with a powder for suspension comprising an active ingredient, wherein upon activation of the dual-chamber pack, the contents of both the chambers are mixed to form an extended release suspension composition which is characterized by having no substantial change in the in-vitro dissolution release profile of the active ingredient upon storage for at least seven days.. . ... Sun Pharmaceutical Industries Limited

04/20/17 / #20170107172

Process for the preparation of 4-dimethylaminocrotonic acid

The present invention provides a process for the preparation of 4-dimethylaminocrotonic acid of formula (ii) or its salts, which is used as an intermediate for the preparation of afatinib or its salts.. . ... Sun Pharmaceutical Industries Limited

03/02/17 / #20170056365

Dapagliflozin compositions

The present invention relates to pharmaceutical compositions comprising a solid dispersion of dapagliflozin and one or more pharmaceutically acceptable excipients, and processes for their preparation. It further relates to a method of treating diabetes using said pharmaceutical compositions.. ... Sun Pharmaceutical Industries Limited

02/23/17 / #20170049774

Sustained release oral pharmaceutical compositions of tofacitinib

The present invention relates to sustained release oral pharmaceutical compositions of tofacitinib comprising tofacitinib, a release controlling polymer, and pharmaceutically acceptable excipients, wherein the sustained release oral pharmaceutical compositions further comprise an outer modified release coating that includes a modified release polymer. The invention also relates to a process for the preparation of the compositions.. ... Sun Pharmaceutical Industries Limited

02/16/17 / #20170042837

Capsule dosage form of metoprolol succinate

This disclosure provides an extended-release capsule dosage form of metoprolol succinate in the form of coated discrete units, wherein said capsule dosage form is bioequivalent to the marketed toprolxl® tablet. The extended-release capsule dosage form comprising coated discrete units can be sprinkled onto food to ease administration to patients who have difficulty swallowing tablets or capsules.. ... Sun Pharmaceutical Industries Limited








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Sun Pharmaceutical Industries Limited in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Sun Pharmaceutical Industries Limited with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###